Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dabigatran etexilate (BIBR 1048) is a thrombin inhibitor, which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
2 mg | 在庫あり | ¥ 7,500 | |||
5 mg | 在庫あり | ¥ 12,000 | |||
10 mg | 在庫あり | ¥ 16,500 | |||
50 mg | 在庫あり | ¥ 20,500 | |||
100 mg | お問い合わせ | ¥ 27,500 | |||
200 mg | お問い合わせ | ¥ 40,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 17,000 |
説明 | Dabigatran etexilate (BIBR 1048) is a thrombin inhibitor, which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. |
ターゲット&IC50 | DTI:4.5 nM (Ki) |
別名 | BIBR 1048 |
分子量 | 627.73 |
分子式 | C34H41N7O5 |
CAS No. | 211915-06-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 116 mg/mL (184.8 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 10 mg/mL (15.9 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dabigatran etexilate 211915-06-9 Proteases/Proteasome Thrombin orally venousthromboembolism effects BIBR 1048 anticoagulant active agent antithrombotic Inhibitor atrial prodrug BIBR-1048 inhibit BIBR1048 Dabigatran fibrillation inhibitor